Multimodality Assessment of Ventricular Scar Arrhythmogenicity.
Launched by ST GEORGE'S, UNIVERSITY OF LONDON · Nov 11, 2020
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Patients will be eligible for this trial both from referrals as an outpatient, where VT has been detected on a heart rhythm monitor or ECG (electrical heart tracing), or as an inpatient where they have been admitted to hospital with symptoms of VT. Our study investigators will discuss the research with the patient and give them the relevant information in an understandable format as part of a Patient Information Sheet so that they can make an informed decision about whether or not to participate in the research.
An MRI scan of the heart is a standard investigation for patients presenting w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Adult inpatients admitted to St George's Hospital London with sustained ventricular tachycardia or outpatients identified from the arrhythmia clinic with significant monomorphic ventricular tachycardia noted on cardiac monitoring who:
- • Have sustained, monomorphic scar-dependent ventricular tachycardia
- • Are symptomatic
- • Failed, unable or unwilling to tolerate anti-arrhythmic medications
- • Able to have a cardiac MRI
- • Have a life expectancy \> 1 year
- • At least 40 days following a myocardial infarction
- Exclusion Criteria:
- • Patients under the age of 18
- • Patients who are unable to give informed consent
- • Pregnant patients
- • Unable to have cardiac MRI
- • Prohibitive procedural risk
- • Unable to tolerate the ablation procedure due to haemodynamic instability
About St George's, University Of London
St George's, University of London is a leading academic institution dedicated to advancing healthcare through innovative research and education. As a prominent clinical trial sponsor, the university leverages its expertise in biomedical sciences, medicine, and health professions to conduct rigorous clinical studies aimed at improving patient outcomes. With a commitment to ethical practices and collaboration across disciplines, St George's fosters an environment that encourages groundbreaking discoveries and the translation of research findings into clinical applications, ultimately enhancing the quality of care in diverse medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Magdi Saba, MD
Study Director
St George's Hospital / SGUL
Anthony Li, MD
Study Director
St George's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials